Postoperative Outcomes Following Posterior Lumbar Fusion in Patients With Multiple Sclerosis

Pramod N Kamalapathy1, Joshua Bell1, Varun Puvanesarajah2

  • 1Department of Orthopaedic Surgery, University of Virginia, Charlottesville, VA.

Abstract

Insights

Patients with multiple sclerosis (MS) face higher risks of complications and increased costs after posterior lumbar fusion (PLF) surgery. Understanding these risks is crucial for better patient counseling and surgical planning.

Area of Science:

  • Neurosurgery
  • Orthopedic Surgery
  • Health Economics

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory neurological disease.
  • Patients with MS are living longer and undergoing more orthopedic procedures.
  • The risks associated with posterior lumbar fusion (PLF) in MS patients are not well-documented.

Purpose of the Study:

  • To analyze postoperative complication rates in MS patients undergoing primary PLF.
  • To assess the economic burden of PLF in MS patients compared to those without MS.

Main Methods:

  • Retrospective review of Medicare database (2006-2013).
  • Included patients undergoing PLF and/or posterior lumbar interbody fusion.
  • Excluded cases with same-day anterior/revision procedures, or history of spine issues, infection, trauma, or neoplasm.
  • Analyzed demographics, comorbidities, 90-day complications, costs, and length of stay using multivariate logistic regression.

Main Results:

  • Significant increase in sepsis, urinary tract infection, deep vein thrombosis, ER visits, and readmissions for MS patients.
  • MS patients incurred higher total hospital charges ($4379 extra) and hospitalization costs ($1679 increase).
  • Increased length of stay observed for MS patients (4.05 vs. 3.61 days).

Conclusions:

  • MS diagnosis is linked to significantly higher postoperative complications and costs after PLF.
  • Physicians must understand MS-related risks to counsel patients effectively before spinal fusion surgery.
  • Informed consent regarding potential complications is imperative for MS patients undergoing PLF.

Related Concept Videos